Market Cap

Nabriva Therapeutics plc Market Capitalization:

$4.5 Million

USD as of Oct. 1, 2023

business Nabriva Therapeutics plc Company Profile

Nabriva Therapeutics plc Main Stock Listing

NASDAQ: NBRV

Market Capitalization History of Nabriva Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Nabriva Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2023 $4.7 M 220.91%
Jan. 1, 2022 $1.5 M -81.56%
Jan. 1, 2021 $8.0 M -80.59%
Jan. 1, 2020 $41.4 M -28.95%
Jan. 1, 2019 $58.2 M -70.63%
Jan. 1, 2018 $198.2 M -18.82%
Jan. 1, 2017 $244.2 M -5.90%
Jan. 1, 2016 $259.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Nabriva Therapeutics plc Categories

Ireland languages Healthcare languages Biotechnology
Ireland Healthcare Ireland Biotechnology

Stocks & Indices

Nabriva Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: NBRV

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.